P Vakil1, S A Ansari2, C G Cantrell3, C S Eddleman4, F H Dehkordi5, J Vranic2, M C Hurley2, H H Batjer4, B R Bendok6, T J Carroll7. 1. From the Departments of Radiology (P.V., S.A.A., J.V., M.C.H., T.J.C.) Biomedical Engineering (P.V., C.G.C., T.J.C.), Northwestern University, Chicago, Illinois. 2. From the Departments of Radiology (P.V., S.A.A., J.V., M.C.H., T.J.C.). 3. Biomedical Engineering (P.V., C.G.C., T.J.C.), Northwestern University, Chicago, Illinois. 4. Department of Neurological Surgery (C.S.E., H.H.B.), University of Texas-Southwestern, Dallas, Texas. 5. Department of Economics and Decision Sciences (F.H.D.), Western Illinois University, Macomb, Illinois. 6. Neurosurgery (B.R.B.). 7. From the Departments of Radiology (P.V., S.A.A., J.V., M.C.H., T.J.C.) Biomedical Engineering (P.V., C.G.C., T.J.C.), Northwestern University, Chicago, Illinois t-carroll@northwestern.edu.
Abstract
BACKGROUND AND PURPOSE: Pathological changes in the intracranial aneurysm wall may lead to increases in its permeability; however the clinical significance of such changes has not been explored. The purpose of this pilot study was to quantify intracranial aneurysm wall permeability (K(trans), VL) to contrast agent as a measure of aneurysm rupture risk and compare these parameters against other established measures of rupture risk. We hypothesized K(trans) would be associated with intracranial aneurysm rupture risk as defined by various anatomic, imaging, and clinical risk factors. MATERIALS AND METHODS: Twenty-seven unruptured intracranial aneurysms in 23 patients were imaged with dynamic contrast-enhanced MR imaging, and wall permeability parameters (K(trans), VL) were measured in regions adjacent to the aneurysm wall and along the paired control MCA by 2 blinded observers. K(trans) and VL were evaluated as markers of rupture risk by comparing them against established clinical (symptomatic lesions) and anatomic (size, location, morphology, multiplicity) risk metrics. RESULTS: Interobserver agreement was strong as shown in regression analysis (R(2) > 0.84) and intraclass correlation (intraclass correlation coefficient >0.92), indicating that the K(trans) can be reliably assessed clinically. All intracranial aneurysms had a pronounced increase in wall permeability compared with the paired healthy MCA (P < .001). Regression analysis demonstrated a significant trend toward an increased K(trans) with increasing aneurysm size (P < .001). Logistic regression showed that K(trans) also predicted risk in anatomic (P = .02) and combined anatomic/clinical (P = .03) groups independent of size. CONCLUSIONS: We report the first evidence of dynamic contrast-enhanced MR imaging-modeled contrast permeability in intracranial aneurysms. We found that contrast agent permeability across the aneurysm wall correlated significantly with both aneurysm size and size-independent anatomic risk factors. In addition, K(trans) was a significant and size-independent predictor of morphologically and clinically defined high-risk aneurysms.
BACKGROUND AND PURPOSE: Pathological changes in the intracranial aneurysm wall may lead to increases in its permeability; however the clinical significance of such changes has not been explored. The purpose of this pilot study was to quantify intracranial aneurysm wall permeability (K(trans), VL) to contrast agent as a measure of aneurysm rupture risk and compare these parameters against other established measures of rupture risk. We hypothesized K(trans) would be associated with intracranial aneurysm rupture risk as defined by various anatomic, imaging, and clinical risk factors. MATERIALS AND METHODS: Twenty-seven unruptured intracranial aneurysms in 23 patients were imaged with dynamic contrast-enhanced MR imaging, and wall permeability parameters (K(trans), VL) were measured in regions adjacent to the aneurysm wall and along the paired control MCA by 2 blinded observers. K(trans) and VL were evaluated as markers of rupture risk by comparing them against established clinical (symptomatic lesions) and anatomic (size, location, morphology, multiplicity) risk metrics. RESULTS: Interobserver agreement was strong as shown in regression analysis (R(2) > 0.84) and intraclass correlation (intraclass correlation coefficient >0.92), indicating that the K(trans) can be reliably assessed clinically. All intracranial aneurysms had a pronounced increase in wall permeability compared with the paired healthy MCA (P < .001). Regression analysis demonstrated a significant trend toward an increased K(trans) with increasing aneurysm size (P < .001). Logistic regression showed that K(trans) also predicted risk in anatomic (P = .02) and combined anatomic/clinical (P = .03) groups independent of size. CONCLUSIONS: We report the first evidence of dynamic contrast-enhanced MR imaging-modeled contrast permeability in intracranial aneurysms. We found that contrast agent permeability across the aneurysm wall correlated significantly with both aneurysm size and size-independent anatomic risk factors. In addition, K(trans) was a significant and size-independent predictor of morphologically and clinically defined high-risk aneurysms.
Authors: E K Fram; R J Herfkens; G A Johnson; G H Glover; J P Karis; A Shimakawa; T G Perkins; N J Pelc Journal: Magn Reson Imaging Date: 1987 Impact factor: 2.546
Authors: Susanne Schnell; Sameer A Ansari; Parmede Vakil; Marie Wasielewski; Maria L Carr; Michael C Hurley; Bernard R Bendok; Hunt Batjer; Timothy J Carroll; James Carr; Michael Markl Journal: J Magn Reson Imaging Date: 2013-10-22 Impact factor: 4.813
Authors: David M Hasan; Kelly B Mahaney; Vincent A Magnotta; David K Kung; Michael T Lawton; Tomoki Hashimoto; H Richard Winn; David Saloner; Alastair Martin; Seymur Gahramanov; Edit Dósa; Edward Neuwelt; William L Young Journal: Arterioscler Thromb Vasc Biol Date: 2012-02-09 Impact factor: 8.311
Authors: Juhana Frösen; Anna Piippo; Anders Paetau; Marko Kangasniemi; Mika Niemelä; Juha Hernesniemi; Juha Jääskeläinen Journal: Stroke Date: 2004-08-19 Impact factor: 7.914
Authors: David O Wiebers; J P Whisnant; J Huston; I Meissner; R D Brown; D G Piepgras; G S Forbes; K Thielen; D Nichols; W M O'Fallon; J Peacock; L Jaeger; N F Kassell; G L Kongable-Beckman; J C Torner Journal: Lancet Date: 2003-07-12 Impact factor: 79.321
Authors: Juan R Cebral; Mariano Vazquez; Daniel M Sforza; Guillaume Houzeaux; Satoshi Tateshima; Esteban Scrivano; Carlos Bleise; Pedro Lylyk; Christopher M Putman Journal: J Neurointerv Surg Date: 2014-05-14 Impact factor: 5.836
Authors: P Vakil; A H Elmokadem; F H Syed; C G Cantrell; F H Dehkordi; T J Carroll; S A Ansari Journal: AJNR Am J Neuroradiol Date: 2016-11-17 Impact factor: 3.825
Authors: C Sang; D F Kallmes; R Kadirvel; M J Durka; Y-H Ding; D Dai; S C Watkins; A M Robertson Journal: Exp Mech Date: 2020-10-27 Impact factor: 2.808